| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 |
| filingDate |
2009-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1af86076fa6f7220d5302bc3be7959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9823889dd90f9c9a56c2e9403b99c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564251cb5047b110099cebb74bf9fbec |
| publicationDate |
2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-2009791-A3 |
| titleOfInvention |
Crystalline and amorphous form of (2R) -2 - {(1S) -6,7-dimethoxy-1- [2- (4-trifluoromethyl-phenyl) -ethyl] -3,4-dihydro-1H-isoquinoline-2-hydrochloride hydrochloride yl} -N-methyl-2-phenyl-acetamide (almorexant) and a process for their preparation |
| abstract |
The present invention relates to a crystalline and amorphous form of (2R) -2 - {(1S) -6,7-dimethoxy-1- [2- (4-trifluoromethylphenyl) ethyl] -3,4-dihydro-1H-isoquinoline-2- yl} -N-methyl-2-phenyl-acetamide I (almorexant) and a process for their preparation. |
| priorityDate |
2009-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |